Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study

We aimed to identify clinical predictors of long-term response to abiraterone (defined as >12 months drug exposure) in a retrospective cohort of metastatic castration-resistant prostate cancer patients treated in post-docetaxel setting at 24 Italian centers. The Cox proportional hazards model was...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Verzoni, Elena, Giorgi, Ugo De, Derosa, Lisa, Caffo, Orazio, Boccardo, Francesco, Facchini, Gaetano, Porcu, Luca, Vincenzo, Fabio De, Zaniboni, Alberto, Chiuri, Vincenzo Emanuele, Fratino, Lucia, Santini, Daniele, Adamo, Vincenzo, Vivo, Rocco De, Dinota, Angelo, Messina, Caterina, Ricotta, Riccardo, Caserta, Claudia, Scavelli, Claudio, Susi, Marina, Tartarone, Alfredo, Surace, Giuseppe, Mosca, Alessandra, Bruno, Michele, Barni, Sandro, Grassi, Paolo, Procopio, Giuseppe
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2016
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5129994/
https://ncbi.nlm.nih.gov/pubmed/27223078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9485
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires